Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 5/20 | 0.35 |
| ▸ | HTR2A | P28223 | 6/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL913232 | 1.00 | AR (0.35) | ARHTR2ASLC6A4KCNH2SCN9A | |
| SCHEMBL3302720 | 0.90 | SCN9A (0.39) | ARHTR2ASLC6A4KCNH2SCN9A | |
| SCHEMBL3302723 | 0.90 | SCN9A (0.39) | ARHTR2ASLC6A4KCNH2SCN9A | |
| SCHEMBL914129 | 0.90 | AR (0.36) | ARHTR2ASLC6A4KCNH2 | |
| SCHEMBL914130 | 0.90 | AR (0.36) | ARHTR2ASLC6A4KCNH2 | |
| SCHEMBL912271 | 0.88 | HTR2A (0.35) | HTR2ASLC6A4KCNH2THRBRORC | |
| SCHEMBL912272 | 0.88 | HTR2A (0.35) | HTR2ASLC6A4KCNH2THRBRORC | |
| SCHEMBL910773 | 0.87 | SCN9A (0.35) | ARHTR2ASLC6A4KCNH2SCN9A | |
| SCHEMBL910774 | 0.87 | SCN9A (0.35) | ARHTR2ASLC6A4KCNH2SCN9A | |
| SCHEMBL3299887 | 0.87 | SCN9A (0.35) | ARHTR2ASLC6A4KCNH2SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110003689-A1 | USE OF POLYMERIC GUANIDINE DERIVATIVES FOR THE CONTROL OF UNWANTED MICROORGANISMS IN CROP PROTECTION | AKA TECHNOLOGY GMBH (AT) | 2011-01-06 | — | — | US | claimed |
| EP-2230915-A2 | USE OF POLYMER GUANIDINE DERIVATIVES FOR COMBATING UNDESIRED MICROORGANISMS IN PEST MANAGEMENT | Aka Technology Gmbh (AT) | 2010-09-29 | — | — | EP | claimed |
| WO-2009077098-A2 | USE OF POLYMER GUANIDINE DERIVATIVES FOR COMBATING UNDESIRED MICROORGANISMS IN PEST MANAGEMENT | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2009-06-25 | — | — | WO | claimed |
| EP-2014167-A1 | Active compound combinations | Bayer CropScience AG (DE) | 2009-01-14 | — | — | EP | claimed |
| US-20110003689-A1 | USE OF POLYMERIC GUANIDINE DERIVATIVES FOR THE CONTROL OF UNWANTED MICROORGANISMS IN CROP PROTECTION | AKA TECHNOLOGY GMBH (AT) | 2011-01-06 | — | — | US | disclosed |
| EP-2230915-A2 | USE OF POLYMER GUANIDINE DERIVATIVES FOR COMBATING UNDESIRED MICROORGANISMS IN PEST MANAGEMENT | Aka Technology Gmbh (AT) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009077098-A2 | USE OF POLYMER GUANIDINE DERIVATIVES FOR COMBATING UNDESIRED MICROORGANISMS IN PEST MANAGEMENT | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2009-06-25 | — | — | WO | disclosed |
| EP-2071954-A1 | Use of polymeric guanidine derivatives for combating unwanted micro-organisms in the protection of plants | Bayer CropScience AG (DE) | 2009-06-24 | — | — | EP | disclosed |
| EP-2014167-A1 | Active compound combinations | Bayer CropScience AG (DE) | 2009-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003689-A1 | USE OF POLYMERIC GUANIDINE DERIVATIVES FOR THE CONTROL OF UNWANTED MICROORGANISMS IN CROP PROTECTION | GDA, GMPS, GANC | AR 4875/4885HTR2A 2990/4885SLC6A4 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.